NeoGenomics NEO Reportable Segment — Other Cost of Operating Revenue

Similar metrics at other companies

EVLVReportable Segment — Other cost of revenue

$13.27M+133%

JAN

JANTotal Reportable Segments — Other Cost Of Operating Revenue

$3.66M+135%

ACHRReportable Segment — Other cost of revenue

$900K—

LZReportable Segment — Other cost of revenue, excluding depreciation, amortization and stock-based compensation

$35.05M+0.2%

OPCHReportable Segment — Other Cost and Expense, Operating

$97.25M-2.0%

MLMReportable Segments — Other Cost Of Operating Revenue

$518M+25.7%

Questions, answered.

What is NeoGenomics's reportable segment — other cost of operating revenue?

NeoGenomics (NEO) reported reportable segment — other cost of operating revenue of $97.88M in Q1 2026.

How has NeoGenomics's reportable segment — other cost of operating revenue changed year-over-year?

NeoGenomics's reportable segment — other cost of operating revenue increased by 14.1% year-over-year, from $85.82M to $97.88M.

What is the long-term trend for NeoGenomics's reportable segment — other cost of operating revenue?

Over 3 years (2022 to 2025), NeoGenomics's reportable segment — other cost of operating revenue has grown at a 9.8% compound annual growth rate (CAGR), from $287.01M to $379.54M.

What does reportable segment — other cost of operating revenue mean?

Includes direct costs associated with providing services, such as laboratory supplies, personnel costs, and logistics, excluding depreciation and amortization. It is a key indicator of the segment's direct operational efficiency and gross margin health.